Coare Biotechnology
COARE Biotechnology, based in Oklahoma City, innovates aggressive cancer treatments by targeting primary tumors and metastasis processes.
Founded
2010COARE Biotechnology, based in Oklahoma City, innovates aggressive cancer treatments by targeting primary tumors and metastasis processes.
Founded in Oklahoma City, COARE Biotechnology is dedicated to revolutionizing cancer treatment by targeting both primary tumors and the biological processes that drive metastasis. The company's mission is to advance therapeutic modalities for patients with aggressive cancers through innovative drug development. COARE Biotechnology offers novel therapeutic platforms designed to improve patient outcomes by addressing the complexities of cancer progression.
COARE Biotechnology has gained global recognition for its pioneering scientific research and development. The team includes renowned experts in oncology and drug development, contributing to the company's esteemed reputation. Key achievements include the identification of critical components that influence metastatic initiation and progression, positioning COARE as a leader in the field. The company's impact is marked by its potential to significantly enhance the effectiveness of cancer treatments, offering hope to patients worldwide.
Companies similar to Coare Biotechnology include Acomhal Research, Curelab Oncology, Sporos Bioventures and Kronos Bio.
Coare Biotechnology was founded in 2010.
Coare Biotechnology's headquarters is located in Oklahoma City, OK, US.
Coare Biotechnology's most recent funding round was for $220.1k (USD) in August 2013.
As of Aug 27, 2013, Coare Biotechnology has disclosed funding of $220.1k (USD). Undisclosed round amounts are excluded.
Coare Biotechnology has 3 employees as of Feb 4, 2024.
kronosbio.com
